Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCompleted
NCT02485691Phase 4Updated May 27, 2022
Sponsor: Sanofi
Prostate Cancer Metastatic
Austria, Belgium, Czechia, France, Germany +8 more
Pre-Clinical White Matter Changes and Associated Connectivity Effects in Fabry DiseaseCompleted
NCT03678324NAUpdated May 26, 2022
Sponsor: University of Utah
Fabry Disease
United States
Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their OffspringCompleted
NCT04460781N/AUpdated May 24, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza
United States
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene MutationTerminated
NCT02906020Phase 2Updated May 24, 2022
Sponsor: Genzyme, a Sanofi Company
Parkinson's Disease
United States, Austria, Canada, France, Germany +11 more
First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic SyndromeTerminated
NCT03594955Phase 1, Phase 2Updated May 24, 2022
Sponsor: Sanofi
Leukaemia
United States, France
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut AllergyCompleted
NCT03793608Phase 2Updated May 19, 2022
Sponsor: Regeneron Pharmaceuticals
Peanut Allergy
United States, Canada
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced MalignanciesTerminated
NCT03367819Phase 1, Phase 2Updated May 16, 2022
Sponsor: Sanofi
Prostate Cancer · Non-small Cell Lung Cancer
United States, France, Italy, Taiwan, United Kingdom
PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult SubjectsCompleted
NCT03069963Phase 1Updated May 12, 2022
Sponsor: Sanofi
Gastroesophageal Reflux Disease
France
A Long-term Follow-up Study Of Multiple Sclerosis Patients Who Participated In Genzyme-sponsored Studies of GZ402668Completed
NCT02313285N/AUpdated May 12, 2022
Sponsor: Genzyme, a Sanofi Company
Progressive Multiple Sclerosis
Germany
Micronutrient Supplement for Nurse BurnoutUnknown
NCT05363410NAUpdated May 5, 2022
Sponsor: Nutraceuticals Research Institute
Burnout, Professional · Stress, Psychological
United States
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive PatientsTerminated
NCT04492254Phase 3Updated May 2, 2022
Sponsor: Thrombosis Research Institute
COVID-19
Australia, Belgium, South Africa
Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompleted
NCT03449758Phase 4Updated Apr 28, 2022
Sponsor: Sanofi
Rheumatoid Arthritis
France
Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1BTerminated
NCT01505062Phase 1, Phase 2Updated Apr 28, 2022
Sponsor: Sanofi
Usher Syndrome · Retinitis Pigmentosa
United States, France
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCompleted
NCT01439165Phase 4Updated Apr 28, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Tetanus · Diphtheria · Pertussis · Whooping Cough
United States, Canada
Post Marketing Surveillance for ADACEL™ in South KoreaCompleted
NCT01137435Phase 4Updated Apr 28, 2022
Sponsor: Sanofi Pasteur, a Sanofi Company
Diphtheria · Tetanus · Pertussis
South Korea
Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female SubjectsCompleted
NCT03070678Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Diabetes Mellitus
France
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.Completed
NCT03703869N/AUpdated Apr 25, 2022
Sponsor: Sanofi
Diabetes
Colombia, Egypt, India, Indonesia, Israel +13 more
Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes MellitusCompleted
NCT03916601Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 1 Diabetes
Germany
Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male ParticipantsCompleted
NCT04982991Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Multiple Sclerosis Healthy Subjects
United Kingdom
A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted ConditionsCompleted
NCT03776227Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus · Healthy Subjects
United States
An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular EventCompleted
NCT03099213Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Coronary Artery Disease
Indonesia
Observational Study Describing the Immune Profile Induced By Pertussis VaccinesCompleted
NCT03147898N/AUpdated Apr 25, 2022
Sponsor: Sanofi
Whooping Cough · Pertussis
Mexico, Panama
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 YearsCompleted
NCT03344029Phase 4Updated Apr 25, 2022
Sponsor: Sanofi
Influenza · Flu
China
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and ExerciseTerminated
NCT03760965Phase 3Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
China
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsCompleted
NCT03350191Phase 1Updated Apr 25, 2022
Sponsor: Sanofi
Type 2 Diabetes Mellitus
Sweden

Previous page Next page